BioGend Therapeutics Co (ROCO:6733) 3-Year Revenue Growth Rate : 285.10% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co 3-Year Revenue Growth Rate?

BioGend Therapeutics Co's Revenue per Share for the three months ended in Mar. 2024 was NT$0.29.

During the past 12 months, BioGend Therapeutics Co's average Revenue per Share Growth Rate was 217.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 285.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of BioGend Therapeutics Co was 285.10% per year. The lowest was 156.80% per year. And the median was 220.95% per year.

Competitive Comparison of BioGend Therapeutics Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, BioGend Therapeutics Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGend Therapeutics Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioGend Therapeutics Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where BioGend Therapeutics Co's 3-Year Revenue Growth Rate falls into.

BioGend Therapeutics Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

BioGend Therapeutics Co (ROCO:6733) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

BioGend Therapeutics Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co (ROCO:6733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th Floor, Number 3, Park Street, Nangang District, Taipei, TWN, 115

Website

https://www.biogend.com.tw

BioGend Therapeutics Co Ltd is a Taiwan based company involved in developing regenerative bio-orthopaedic medicine to advance the clinical science of maintaining healthy joints in skeletal system. The Company is primarily engaged in the research and development of bone medical device related products. Its products under development include Big-001, Big-006 and Big-009.

BioGend Therapeutics Co (ROCO:6733) Headlines

No Headlines